We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
326
Archer Daniels Midland
ADM
$41.7B
$14.7M 0.06%
359,779
+244,500
+212% +$11.4M
BPOP icon
327
Popular Inc
BPOP
$10.5B
$14.7M 0.06%
312,100
+124,600
+66% +$6.42M
P
328
Everpure Inc
P
$32.3B
$14.7M 0.06%
913,772
+53,300
+6% +$1.05M
HDS
329
DELISTED
HD Supply Holdings, Inc.
HDS
$14.5M 0.06%
386,016
-82,100
-18% -$3.16M
MTB icon
330
M&T Bank
MTB
$34B
$14.5M 0.06%
100,974
+18,972
+23% +$3.03M
MS icon
331
Morgan Stanley
MS
$324B
$14.4M 0.06%
364,203
-50,739
-12% -$2.21M
QGEN icon
332
Qiagen
QGEN
$8.77B
$14.3M 0.06%
392,761
-11,072
-3% -$411K
LKQ icon
333
LKQ Corp
LKQ
$5.92B
$14.3M 0.06%
601,025
-22,650
-4% -$616K
AKAM icon
334
Akamai
AKAM
$15.1B
$14.2M 0.06%
232,378
+90,200
+63% +$6M
HSY icon
335
Hershey
HSY
$34.2B
$14M 0.06%
131,003
+16,500
+14% +$1.75M
CNC icon
336
Centene
CNC
$33.4B
$14M 0.06%
243,362
-213,964
-47% -$14.3M
ATO icon
337
Atmos Energy
ATO
$27.4B
$14M 0.06%
150,983
+16,900
+13% +$1.62M
ROIC
338
DELISTED
Retail Opportunity Investments Corp.
ROIC
$14M 0.06%
881,455
-10,040
-1% -$176K
SPY icon
339
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$13.9M 0.06%
55,547
+30,537
+122% +$8.23M
FTV icon
340
Fortive
FTV
$17B
$13.7M 0.06%
321,747
-122,545
-28% -$5.76M
URI icon
341
United Rentals
URI
$61.6B
$13.6M 0.06%
132,264
-5,965
-4% -$718K
TFCFA
342
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$13.6M 0.06%
281,645
-1,356
-0.5% -$64.3K
SCHW
343
Charles Schwab
SCHW
$186B
$13.6M 0.06%
326,300
-22,354
-6% -$1.01M
AMED
344
DELISTED
Amedisys
AMED
$13.5M 0.06%
115,601
+81,301
+237% +$9.58M
CMS icon
345
CMS Energy
CMS
$20.7B
$13.5M 0.06%
272,398
+39,800
+17% +$2.01M
MAN icon
346
ManpowerGroup
MAN
$2.72B
$13.4M 0.06%
206,300
-9,500
-4% -$722K
EXPD icon
347
Expeditors International
EXPD
$25.2B
$13.3M 0.06%
195,953
+47,400
+32% +$3.33M
TEAM icon
348
Atlassian
TEAM
$48B
$13.3M 0.06%
149,500
-34,047
-19% -$2.7M
DE icon
349
Deere & Co
DE
$184B
$13.2M 0.06%
88,777
-6,689
-7% -$980K
JNPR
350
DELISTED
Juniper Networks
JNPR
$13.2M 0.06%
491,671
+476,300
+3,099% +$13.5M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.